Phase 1 Influenza Prevention Clinical Trials

2 recruitingPhase 1

What is a Phase 1 trial?

Phase 1 trials test a new treatment in a small group of people for the first time. The primary goal is to evaluate safety, determine a safe dosage range, and identify side effects. These studies typically enroll 20 to 80 participants.

Showing 1–2 of 2 trials

Recruiting

Phase 1

Quadrivalent Influenza HA Stem Vaccine VRC-FLUMOS0122-00-VP (SteMos1) With and Without ALFQ Adjuvant in Healthy Adults

Influenza PreventionPandemic Influenza Prevention

National Institute of Allergy and Infectious Diseases (NIAID)56 enrolled1 locationNCT07111078

Recruiting

Phase 1

Evaluating the Dose, Safety, Tolerability, and Immunogenicity of Mosaic Hexavalent Influenza Vaccine VRCFLUMOS0116-00-VP (FluMos-v2) With and Without ALFQ Adjuvant in Healthy Adults

Influenza PreventionSeasonal Influenza

National Institute of Allergy and Infectious Diseases (NIAID)45 enrolled1 locationNCT06863142